New gel shows promise for thinning hair in early trial

NCT ID NCT06393452

Completed Disease control Sponsor: Pelage Pharmaceuticals, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a gel called PP405 for male and female pattern baldness. 78 adults used the gel or a placebo for 28 days, then everyone could use the real gel for 3 more months. The main goals were to check safety and how the body processes the drug.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alopecia androgenetic alopecia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANDROGENETIC ALOPECIA

Contacts and locations

Locations

California Dermatology & Clinical Research Institute

Encinitas, California, 92024, United States
Clinical Trials Research Institute

Thousand Oaks, California, 91320, United States
Dawes Fretzin Clinical Research Group, LLC

Indianapolis, Indiana, 46250, United States
DermResearch

Austin, Texas, 78759, United States
Jordan Valley Dermatology Center

South Jordan, Utah, 84095, United States
Minnesota Clinical Study Center

New Brighton, Minnesota, 55112, United States
Stride Clinical Research LLC

Sugar Land, Texas, 77479, United States
Virginia Clinical Research, Inc.

Norfolk, Virginia, 23502, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.